Ein Arzt berät einen Patienten (Symbolbild).
Mittwoch, 19.12.2012 18:40 von | Aufrufe: 334

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Zillow, Inc. (Z) and SinoHub, Inc. (SIHI) and Investigation of Peregrine Pharmaceuticals, Inc. (PPHM)

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

NEW YORK, Dec. 19, 2012 /PRNewswire/ --

Blyth, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the District of Connecticut on behalf of investors who purchased Blyth, Inc. (NYSE: BTH) stock between March 14, 2012 and November 6, 2012.

For more information, click here: http://zlk.9nl.com/blyth-bth.  You have until January 12, 2013to request that the Court appoint you as lead plaintiff.

Zillow, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Western District of Washington on behalf of investors who acquired Zillow, Inc. (Nasdaq: Z) stock between February 15, 2012 and November 6, 2012.


ARIVA.DE Börsen-Geflüster

Kurse

-  
0,00%
Blyth Chart
Peregrine Pharmaceuticals Chart
-  
0,00%
SINOHUB INC Chart
43,13 $
+1,70%
Zillow Group A Chart

For more information, click here: http://zlk.9nl.com/zillow-z/ You have until January 28, 2013to request that the Court appoint you as lead plaintiff.

SinoHub, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased SinoHub, Inc. (OTC: SIHI) stock between May 17, 2010 and August 21, 2012.

For more information, click here: http://zlk.9nl.com/sinohub-sihi/.  You have until January 21, 2013to request that the Court appoint you as lead plaintiff.

Peregrine Pharmaceuticals, Inc.

Levi & Korsinsky is investigating potential claims on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities concerning possible breaches of fiduciary duty in connection with the disclosure of the discovery of major discrepancies in the treatment group of its Bavituxmab Phase II Second-Line Non-Small Cell Lung Cancer Trial.

For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/.  

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Werbung

Mehr Nachrichten zur Peregrine Pharmaceuticals Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News